See more : Brembo N.V. (0RPV.L) Income Statement Analysis – Financial Results
Complete financial analysis of Sumitomo Chemical Company, Limited (SOMMY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sumitomo Chemical Company, Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- EASY BIO,Inc. (353810.KQ) Income Statement Analysis – Financial Results
- Bombardier Inc. (BBD-PB.TO) Income Statement Analysis – Financial Results
- Tianci International, Inc. (CIIT) Income Statement Analysis – Financial Results
- Midland Exploration Inc. (MD.V) Income Statement Analysis – Financial Results
- Clime Capital Limited (CAM.AX) Income Statement Analysis – Financial Results
Sumitomo Chemical Company, Limited (SOMMY)
About Sumitomo Chemical Company, Limited
Sumitomo Chemical Company, Limited engages in Chemicals & Plastics, energy and functional materials, IT-related chemicals, health and crop sciences, pharmaceuticals, and other businesses worldwide. Its Essential Chemicals & Plastics segment offers synthetic resins, such as polyethylene, polypropylene, and polymethyl methacrylate resins; raw materials for synthetic fibers; and various industrial chemicals. The company's Energy & Functional Materials segment provides alumina and aluminum products used for energy products; resorcinol for tires, wood adhesives, flame retardants, and ultraviolet ray absorbants; polymer additives and rubber chemicals; synthetic rubber for tires, shoes, construction materials, and other applications; and engineering plastics and lithium-ion secondary battery materials for use in electronic components and next-generation vehicles. Its IT-Related Chemicals segment provides polarizing films, touch screen sensor panels, and color resists and polymer OLED for LC and OLED displays; photoresists and high-purity chemicals for the semiconductor manufacturing process; and compound semiconductor materials for antenna switches and other components of communication terminal equipment. The company's Health & Crop Sciences segment offers crop protection chemicals, fertilizers, feed additives, and household insecticides; active pharmaceutical ingredients and intermediates; and products to control infectious diseases. Its Pharmaceuticals segment provides prescription and diagnostic pharmaceuticals. The company's Others segment supplies electric power and steam; designs, constructs, and supervises chemical plants; provides transportation and warehousing services; and conducts physical property and environmental analysis. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,446.89B | 2,895.28B | 2,286.98B | 2,225.80B | 2,318.57B | 2,318.57B | 2,190.51B | 1,954.28B | 2,101.76B | 2,376.70B | 2,243.79B | 1,952.49B | 1,947.88B | 1,982.44B | 1,620.92B | 1,788.22B | 1,896.54B | 1,790.03B | 1,556.61B | 1,296.32B | 1,158.40B | 1,111.13B | 1,018.35B | 1,040.95B | 950.34B | 927.66B | 1,020.34B | 1,011.60B | 951.92B |
| Cost of Revenue | 1,947.20B | 2,074.36B | 1,515.78B | 1,519.05B | 1,576.30B | 1,576.30B | 1,440.64B | 1,285.76B | 1,404.80B | 1,727.80B | 1,639.65B | 1,449.55B | 1,418.46B | 1,409.52B | 1,192.34B | 1,412.61B | 1,454.42B | 1,338.14B | 1,138.54B | 933.89B | 850.19B | 798.00B | 724.95B | 746.65B | 684.63B | 682.33B | 759.54B | 760.44B | 708.57B |
| Gross Profit | 499.70B | 820.93B | 771.20B | 706.76B | 742.27B | 742.27B | 749.87B | 668.52B | 696.96B | 648.89B | 604.15B | 502.94B | 529.42B | 572.92B | 428.57B | 375.61B | 442.12B | 451.88B | 418.07B | 362.42B | 308.21B | 313.13B | 293.41B | 294.30B | 265.71B | 245.33B | 260.80B | 251.16B | 243.35B |
| Gross Profit Ratio | 20.42% | 28.35% | 33.72% | 31.75% | 32.01% | 32.01% | 34.23% | 34.21% | 33.16% | 27.30% | 26.93% | 25.76% | 27.18% | 28.90% | 26.44% | 21.00% | 23.31% | 25.24% | 26.86% | 27.96% | 26.61% | 28.18% | 28.81% | 28.27% | 27.96% | 26.45% | 25.56% | 24.83% | 25.56% |
| Research & Development | 0.00 | 191.18B | 171.92B | 178.65B | 174.32B | 163.47B | 165.34B | 154.65B | 152.89B | 145.03B | 138.57B | 121.84B | 118.48B | 133.83B | 114.17B | 127.18B | 101.86B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 887.12B | 878.26B | 631.27B | 575.14B | 590.06B | 590.06B | 557.89B | 39.65B | 41.50B | 46.78B | 46.38B | 44.85B | 43.72B | 45.68B | 35.21B | 33.19B | 339.73B | 312.26B | 297.28B | 257.24B | 241.59B | 239.61B | 224.57B | 209.63B | 195.56B | 186.07B | 190.88B | 194.35B | 188.53B |
| Selling & Marketing | 0.00 | 150.03B | 119.14B | 100.85B | 99.35B | 99.11B | 92.29B | 44.42B | 48.49B | 49.46B | 43.44B | 34.92B | 40.93B | 38.34B | 25.91B | 22.46B | 21.36B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 887.12B | 878.26B | 631.27B | 575.14B | 590.06B | 590.06B | 557.89B | 84.07B | 90.00B | 96.24B | 89.82B | 79.77B | 84.65B | 84.02B | 61.12B | 55.64B | 339.73B | 312.26B | 297.28B | 257.24B | 241.59B | 239.61B | 224.57B | 209.63B | 195.56B | 186.07B | 190.88B | 194.35B | 188.53B |
| Other Expenses | 101.40B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -6.12B | -2.30B | -4.48B | -1.72B | -1.56B | -3.54B | 2.95B | 804.00M | 2.19B | -4.00B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 988.52B | 845.11B | 621.62B | 578.47B | 596.50B | 596.50B | 554.27B | 534.18B | 532.52B | 521.55B | 503.30B | 457.93B | 468.73B | 385.66B | 275.45B | 269.06B | 339.73B | 312.26B | 291.43B | 253.81B | 237.11B | 233.18B | 219.53B | 198.31B | 170.80B | 175.51B | 190.88B | 194.35B | 188.53B |
| Cost & Expenses | 2,935.72B | 2,919.47B | 2,137.40B | 2,097.52B | 2,172.80B | 2,172.80B | 1,994.91B | 1,819.95B | 1,937.32B | 2,249.35B | 2,142.95B | 1,907.48B | 1,887.20B | 1,795.18B | 1,467.79B | 1,681.67B | 1,794.14B | 1,650.40B | 1,429.96B | 1,187.70B | 1,087.30B | 1,031.19B | 944.48B | 944.96B | 855.43B | 857.84B | 950.42B | 954.79B | 897.10B |
| Interest Income | 73.00B | 70.84B | 19.87B | 13.18B | 16.62B | 16.62B | 11.54B | 3.11B | 3.18B | 2.60B | 1.91B | 1.96B | 1.78B | 1.99B | 2.25B | 2.81B | 9.25B | 7.14B | 5.70B | 4.21B | 4.96B | 3.99B | 4.53B | 5.49B | 4.88B | 4.99B | 5.29B | 4.89B | 8.73B |
| Interest Expense | 46.96B | 39.62B | 19.18B | 20.22B | 11.22B | 11.22B | 21.65B | 10.50B | 11.98B | 13.48B | 12.84B | 12.95B | 12.40B | 13.02B | 12.07B | 12.27B | 12.00B | 11.03B | 7.92B | 7.20B | 7.81B | 9.31B | 11.94B | 13.98B | 13.60B | 14.50B | 16.88B | 21.13B | 25.13B |
| Depreciation & Amortization | 157.52B | 167.96B | 156.67B | 136.02B | 131.74B | 112.50B | 107.10B | 110.31B | 116.60B | 119.18B | 115.73B | 115.48B | 114.89B | 147.01B | 116.11B | 140.71B | 124.98B | 113.87B | 104.91B | 88.17B | 82.48B | 69.03B | 79.25B | 64.61B | 75.36B | 69.17B | 57.56B | 61.97B | 69.95B |
| EBITDA | -258.31B | 110.63B | 338.23B | 272.22B | 266.08B | 264.98B | 301.22B | 244.62B | 281.05B | 246.52B | 216.58B | 178.69B | 151.23B | 235.72B | 169.48B | 224.79B | 265.23B | 305.97B | 271.41B | 217.02B | 162.60B | 141.55B | 148.95B | 142.97B | 189.10B | 145.38B | 133.62B | 131.42B | 124.66B |
| EBITDA Ratio | -10.56% | 7.18% | 12.81% | 12.69% | 13.46% | 13.46% | 16.87% | 14.71% | 14.26% | 12.20% | 10.76% | 9.15% | 7.80% | 17.32% | 16.34% | 12.57% | 14.94% | 17.62% | 17.50% | 17.70% | 14.70% | 13.73% | 16.79% | 16.88% | 19.90% | 15.67% | 13.10% | 12.63% | 14.16% |
| Operating Income | -488.83B | -30.98B | 137.12B | 137.52B | 182.97B | 182.97B | 250.92B | 134.34B | 164.45B | 127.35B | 100.84B | 45.02B | 60.69B | 87.96B | 51.46B | 2.11B | 102.40B | 139.62B | 120.79B | 105.18B | 66.62B | 73.52B | 68.84B | 84.67B | 70.15B | 59.26B | 69.91B | 56.81B | 54.81B |
| Operating Income Ratio | -19.98% | -1.07% | 6.00% | 6.18% | 7.89% | 7.89% | 11.46% | 6.87% | 7.82% | 5.36% | 4.49% | 2.31% | 3.12% | 4.44% | 3.17% | 0.12% | 5.40% | 7.80% | 7.76% | 8.11% | 5.75% | 6.62% | 6.76% | 8.13% | 7.38% | 6.39% | 6.85% | 5.62% | 5.76% |
| Total Other Income/Expenses | 26.03B | 57.57B | -45.20B | -9.45B | 56.75B | 36.16B | 48.83B | 10.86B | -6.88B | -10.64B | -14.64B | -32.67B | -36.74B | -12.26B | -10.16B | -50.85B | 25.85B | 41.44B | 37.80B | 16.48B | 5.69B | -10.31B | -11.07B | -20.30B | -38.11B | -23.82B | -24.05B | -8.49B | -25.23B |
| Income Before Tax | -462.79B | 231.00M | 137.80B | 130.48B | 188.37B | 188.37B | 240.81B | 145.19B | 157.57B | 116.70B | 86.20B | 12.34B | 23.95B | 75.70B | 41.30B | -48.74B | 128.24B | 181.06B | 158.59B | 121.66B | 72.31B | 63.21B | 57.77B | 64.38B | 35.16B | 35.44B | 40.81B | 48.32B | 29.59B |
| Income Before Tax Ratio | -18.91% | 0.01% | 6.03% | 5.86% | 8.12% | 8.12% | 10.99% | 7.43% | 7.50% | 4.91% | 3.84% | 0.63% | 1.23% | 3.82% | 2.55% | -2.73% | 6.76% | 10.11% | 10.19% | 9.39% | 6.24% | 5.69% | 5.67% | 6.18% | 3.70% | 3.82% | 4.00% | 4.78% | 3.11% |
| Income Tax Expense | 2.66B | 47.10B | 69.73B | 76.08B | 35.90B | 35.90B | 62.65B | 28.14B | 45.17B | 45.60B | 31.24B | 52.75B | 8.30B | 34.85B | 11.34B | -1.60B | 44.13B | 65.92B | 51.53B | 43.60B | 30.97B | 25.76B | 23.32B | 24.84B | 16.73B | 15.33B | 18.70B | 26.85B | 11.06B |
| Net Income | -311.84B | 6.99B | 46.04B | 30.93B | 117.99B | 117.99B | 133.77B | 76.54B | 81.45B | 52.19B | 36.98B | -51.08B | 5.59B | 24.43B | 14.72B | -59.16B | 63.08B | 93.86B | 90.67B | 64.45B | 34.32B | 31.13B | 30.21B | 34.08B | 18.43B | 20.12B | 22.12B | 21.47B | 18.53B |
| Net Income Ratio | -12.74% | 0.24% | 2.01% | 1.39% | 5.09% | 5.09% | 6.11% | 3.92% | 3.88% | 2.20% | 1.65% | -2.62% | 0.29% | 1.23% | 0.91% | -3.31% | 3.33% | 5.24% | 5.82% | 4.97% | 2.96% | 2.80% | 2.97% | 3.27% | 1.94% | 2.17% | 2.17% | 2.12% | 1.95% |
| EPS | -190.69 | 4.27 | 28.16 | 18.92 | 72.17 | 360.83 | 409.05 | 234.05 | 249.20 | 159.65 | 113.10 | -156.23 | 17.10 | 74.30 | 44.60 | -179.19 | 191.00 | 284.10 | 274.00 | 194.70 | 103.58 | 93.71 | 91.25 | 103.78 | 56.65 | 62.03 | 68.19 | 66.19 | 57.13 |
| EPS Diluted | -190.69 | 4.27 | 28.16 | 18.92 | 72.17 | 360.83 | 409.05 | 233.85 | 248.90 | 159.20 | 112.80 | -156.23 | 17.10 | 74.30 | 44.60 | -179.19 | 191.00 | 284.05 | 274.00 | 193.45 | 102.86 | 92.64 | 90.24 | 102.10 | 56.31 | 61.57 | 66.77 | 64.52 | 56.14 |
| Weighted Avg Shares Out | 1.64B | 1.63B | 1.63B | 1.63B | 1.64B | 327.01M | 327.02M | 327.04M | 326.86M | 326.89M | 326.91M | 326.93M | 326.93M | 328.85M | 330.18M | 330.18M | 330.25M | 330.38M | 330.89M | 331.03M | 331.33M | 332.24M | 331.08M | 328.38M | 325.27M | 324.33M | 324.35M | 324.33M | 324.34M |
| Weighted Avg Shares Out (Dil) | 1.64B | 1.64B | 1.63B | 1.63B | 1.64B | 327.01M | 327.02M | 327.04M | 327.24M | 327.84M | 327.81M | 326.93M | 326.93M | 328.85M | 330.18M | 330.18M | 330.25M | 330.43M | 330.89M | 333.17M | 333.64M | 336.08M | 334.80M | 333.78M | 327.24M | 326.75M | 331.23M | 332.75M | 330.03M |
Sumitomo Chemical Company, Limited (SOMMY) Q2 2024 Earnings Call Transcript
Aluminum Hydroxide Industry Business Report 2023-2030 with Focus on 40+ Select Players Including Aluminum Corp of China, J.M. Huber, Nabaltec, Showa Denko, Sumitomo Chemical, & The R.J.
Sumitomo Chemical Company, Limited (SOMMY) Q1 2025 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports